Goldman Sachs’s Aehr Test Systems AEHR Stock Holding History
Bought
Maintained
Sold
Other funds holding AEHR
AIC
VCM
VPM
NCGI
Goldman Sachs's AEHR Position: Q1 2026 in Review
Goldman Sachs increased its Aehr Test Systems (AEHR) stake by 617% in Q1 2026, buying an estimated $34.7M and bringing the position to 1,262,043 shares worth $46.8M. The position accounts for 0.01% of the portfolio, ranked #1628.
Goldman Sachs first reported a position in AEHR in Q1 2021 and has held it in 19 quarters since. The position peaked at $86M in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.
- Goldman Sachs held 1,262,043 shares of Aehr Test Systems worth $46.8M as of Q1 2026.
- Goldman Sachs bought 1,086,001 Aehr Test Systems shares in Q1 2026, an estimated $34.7M.
- Aehr Test Systems made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1628 holding.
- Goldman Sachs first reported a position in Aehr Test Systems in Q1 2021 and has held it in 19 quarters since.
- Goldman Sachs's Aehr Test Systems position peaked at $86M in Q3 2023.
- 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.